Exail Technologies (LON:0OHC)
83.30
-0.18 (-0.22%)
At close: Dec 19, 2025
Exail Technologies Revenue
Exail Technologies had revenue of 230.79M EUR in the half year ending June 30, 2025, with 39.94% growth. This brings the company's revenue in the last twelve months to 453.29M, up 26.96% year-over-year. In the year 2024, Exail Technologies had annual revenue of 397.57M with 14.61% growth.
Revenue (ttm)
453.29M EUR
Revenue Growth
+26.96%
P/S Ratio
3.21
Revenue / Employee
226.08K EUR
Employees
2,005
Market Cap
1.25B GBP
Revenue Chart
* This company reports financials in EUR.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 397.57M | 50.69M | 14.61% |
| Dec 31, 2023 | 346.88M | 156.73M | 82.42% |
| Dec 31, 2022 | 190.15M | 62.85M | 49.37% |
| Dec 31, 2021 | 127.30M | -31.51M | -19.84% |
| Dec 31, 2020 | 158.81M | -124.59M | -43.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Shell | 200.18B |
| BP p.l.c. | 138.32B |
| Unilever | 51.24B |
| AstraZeneca | 43.24B |
| HSBC Holdings | 43.13B |
| Rio Tinto Group | 39.22B |
| GSK plc | 32.17B |
| Barclays | 26.02B |